Our observation that the levels of CCL2, CCL11, CCL17, and PDGF-BB, could explain 80% of the variability in the proportion of HMCs in SCD patients and the healthy controls, suggests that these chemokines contribute to setting the basal levels of HMCs and HPCs in the circulation. This evidence concerns the gene CCL11 and Schnyder corneal dystrophy.